Bryan Johnson, renowned for investing millions on anti‑aging investigation, now has an terminal autoimmune disease.
The illness makes his stomach damage itself, leaving severe internal pain.
Johnson pushed intense health regimens to reach 160 years old, hoping for a lifespan far beyond typical limits.
Doctors confirm no known cure is available yet for his condition, highlighting the seriousness of his situation.
The news broke after multiple media outlets covered his diagnosis, prompting widespread discussion online.
Friends and followers expressed sympathy, while critics challenged the practicality of his longevity pursuits.
The situation highlights the complexity of experimental health strategies and may influence future public perception of anti‑aging initiatives.